Prosecution Insights
Last updated: August 06, 2026

National Health Research Institutes

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (67%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GROSS, JASON PATRICK 1 63.6% +48.3%
HECK, BRYAN WILLIAM 1 45.7% +69.4%
BALLARD, KIMBERLY 1 53.9% +48.0%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18476345 PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF HECK, BRYAN WILLIAM 26d overdue
18980664 INTERACTIVE ORAL CAVITY PHOTOGRAPHY SYSTEM AND ARTIFICIAL INTELLIGENCE IMAGE RECOGNITION ORAL CAVITY CANCER GROSS, JASON PATRICK
17996742 METHODS FOR PREDICTION, DETECTION AND MONITORING OF SUBSTANCEUSE DISORDERS AND/OR AN INFECTION BALLARD, KIMBERLY

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18476345 PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF HECK, BRYAN WILLIAM 26d overdue
18980664 INTERACTIVE ORAL CAVITY PHOTOGRAPHY SYSTEM AND ARTIFICIAL INTELLIGENCE IMAGE RECOGNITION ORAL CAVITY CANCER GROSS, JASON PATRICK
17996742 METHODS FOR PREDICTION, DETECTION AND MONITORING OF SUBSTANCEUSE DISORDERS AND/OR AN INFECTION BALLARD, KIMBERLY

Top Art Units

Art UnitApps
3797 1
1643 1
1675 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18980664 INTERACTIVE ORAL CAVITY PHOTOGRAPHY SYSTEM AND ARTIFICIAL INTELLIGENCE IMAGE RECOGNITION ORAL CAVITY CANCER GROSS, JASON PATRICK 3797 §101§103§112 Non-Final OA Pending Dec 13, 2024
18476345 PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF HECK, BRYAN WILLIAM 1643 §102§103§112Other Non-Final OA 26d overdue Pending Sep 28, 2023
17996742 METHODS FOR PREDICTION, DETECTION AND MONITORING OF SUBSTANCEUSE DISORDERS AND/OR AN INFECTION BALLARD, KIMBERLY 1675 §101§112 Non-Final OA Pending Oct 20, 2022

Managing National Health Research Institutes's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month